Embryoxite
Techstars '25Florida, US · Founded 2020 · 11 employees on LinkedIn · 2 known investors
Find your way into Embryoxite
566 people in our graph share verified history with the Embryoxite team — schools, employers, funds. One of them is your warm intro.
Rustyunlockedknows Delfina Vilieri · together at Techstars (overlapped)
×11knows the team · via Techstars
Embryoxite develops AI-powered, non-invasive embryo analysis that predicts IVF implantation success by analyzing embryo culture medium, alongside an IVF electronic medical record and clinic management platform. It serves fertility clinics and reproductive medicine specialists, offering predictive analytics for embryo selection and ovarian reserve assessment.
Founders & leadership
Embryoxite was founded in 2020 by Delfina Vilieri.
DV
Delfina VilieriinFounder · CEO at EmbryoxiteDelfina Vilieri is founder and CEO of Embryoxite, which develops AI and metabolomics-based analysis to predict embryo viability for IVF. She has a background in engineering, process optimization, and strategic consulting, and previously founded Traszar.
M
MarisainMetabolomics Specialist / Metabolome Advisor
Investors · 2
In the news
Frequently asked questions
- What does Embryoxite do?
- Embryoxite develops AI-powered, non-invasive embryo analysis that predicts IVF implantation success by analyzing embryo culture medium, alongside an IVF electronic medical record and clinic management platform. It serves fertility clinics and reproductive medicine specialists, offering predictive analytics for embryo selection and ovarian reserve assessment.
- Who founded Embryoxite?
- Embryoxite was founded by Delfina Vilieri in 2020.
- Who are Embryoxite's investors?
- Embryoxite's investors include GRIDX, Techstars.
- Where is Embryoxite headquartered?
- Embryoxite is headquartered in Florida, US.